rosiglitazone has been researched along with puerarin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guan, C; Ou-Yang, Y; Sun, YH; Xiao, SZ; Xu, ME; Zheng, XX | 1 |
Ao, X; Hou, Q; Li, G; Zhang, Y | 1 |
1 trial(s) available for rosiglitazone and puerarin
Article | Year |
---|---|
[Puerarin combined with avandia for diabetic nephropathy].
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Isoflavones; Male; Middle Aged; Rosiglitazone; Thiazolidinediones | 2012 |
1 other study(ies) available for rosiglitazone and puerarin
Article | Year |
---|---|
The study of anti-metabolic syndrome effect of puerarin in vitro.
Topics: Actins; Adipocytes; Animals; Apoptosis; Calcium; Cell Differentiation; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Endothelial Cells; Glucose; Humans; Hypoglycemic Agents; Isoflavones; Male; PPAR gamma; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2005 |